A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 μg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight

Author： Endrikat Jan   Sandri Mirella   Gerlinger Christoph   Rübig Alexander   Schmidt Werner   Fortier Michel  

Publisher： Informa Healthcare

ISSN： 1473-0782

Source： The European Journal of Contraception and Reproductive Health Care, Vol.12, Iss.3, 2007-01, pp. : 220-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 g of ethinyl estradiol on the human endometrium

By Ludicke F.   Johannisson E.   Helmerhorst F.M.   Campana A.   Foidart J.-M.   Heithecker R.  

Fertility and Sterility, Vol. 76, Iss. 1, 2001-07 ,pp. : 102-107

Elsevier

Access to resources Recommend Favorite

Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: Results from the multicentre, randomised, double-blind, active-controlled HARMONY II study

By Macìas G.  

Journal of Obstetrics & Gynaecology, Vol. 33, Iss. 6, 2013-08 ,pp. : 591-596

Informa Healthcare

Access to resources Recommend Favorite

Transfer of drospirenone to breast milk after a single oral administration of 3 mg drospirenone + 30 μg ethinylestradiol to healthy lactating women

By Blode H.   Foidart J.-M.   Heithecker R.  

The European Journal of Contraception and Reproductive Health Care, Vol. 6, Iss. 3, 2001-09 ,pp. : 167-171

Informa Healthcare

Access to resources Recommend Favorite

Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms

By Apter D.   Borsos A.   Baumgärtner W.   Melis G.-B.   Vexiau-Robert D.   Colligs-Hakert A.   Palmer M.   Kelly S.  

The European Journal of Contraception and Reproductive Health Care, Vol. 8, Iss. 1, 2003-03 ,pp. : 37-51

Informa Healthcare

Access to resources Recommend Favorite

Body weight change during use of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake

By Endrikat J.   Gerlinger C.   Cronin M.   Wessel J.   Ruebig A.   Rosenbaum P.   Düsterberg B.  

The European Journal of Contraception and Reproductive Health Care, Vol. 6, Iss. 4, 2001-12 ,pp. : 199-204

Informa Healthcare

Access to resources Recommend Favorite